Tetra Discovery Partners clinical trials
Acquired by Shionogi, May 26, 2020 · source ↗
The registry lists 9 studies whose lead sponsor is Tetra Discovery Partners. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 31, 2026.
Before and after it joined Shionogi
- First submitted before Tetra Discovery Partners became part of Shionogi
- 6
- First submitted after Tetra Discovery Partners became part of Shionogi
- 3
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Tetra Discovery Partners9 studies
Something wrong with this grouping? Tell us on the Shionogi page.
Studies
Recruiting first, then most recently updated. Showing 9 of 9. All Shionogi studies →
- A Randomized Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X SyndromeCompletedNCT05163808Phase 2/3
Sponsor listed in the registry: Tetra Discovery Partners · First submitted after Tetra Discovery Partners became part of Shionogi
- A Study of BPN14770 in Male Adults (Aged 18 to 45) With Fragile X SyndromeCompletedNCT05358886Phase 3
Sponsor listed in the registry: Tetra Discovery Partners · First submitted after Tetra Discovery Partners became part of Shionogi
- An Open-Label Extension Study of BPN14770 in Subjects With Fragile X SyndromeActive, not recruitingNCT05367960Phase 3
Sponsor listed in the registry: Tetra Discovery Partners · First submitted after Tetra Discovery Partners became part of Shionogi
- Tetra PICASSO AD Trial: Study to Evaluate Effects of BPN14770 in Early Alzheimer's SubjectsCompletedNCT03817684Phase 2
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi
- A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X SyndromeCompletedNCT03569631Phase 2
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi
- A Phase 1, Open-Label, PET Study of T2310 & BPN14770WithdrawnNCT04044781Phase 1
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi
- Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy VolunteersCompletedNCT03030105Phase 1
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi
- BPN14770 Single Ascending Dose Study in Healthy Male and Female SubjectsCompletedNCT02648672Phase 1
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi
- A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female SubjectsCompletedNCT02840279Phase 1
Sponsor listed in the registry: Tetra Discovery Partners · First submitted before Tetra Discovery Partners became part of Shionogi